RFX1 and autoimmune disease: Therefore, we hypothesized that abnormally elevated LPS in patients with inflammatory and autoimmune diseases reduced the concentration of ADP in macrophages, thereby activating the regulatory function of RFX1 and promoting the inflammatory response.